首页> 外文期刊>European journal of medical research. >Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
【24h】

Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy

机译:玻璃体内贝贝磺酸盐在中央性浆液性脉络膜视网膜病变中的近期疗效

获取原文
获取外文期刊封面目录资料

摘要

PurposeTo report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC).MethodsThis is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC. Main measures included fundoscopy, Snellen visual acuity (VA) testing, fluorescein angiography and optical coherence tomography (OCT).ResultsWe present anatomical and functional evidences, obtained as early as eleven days after the treatment, of the efficacy of intravitreal dobesilate, in the treatment of chronic CSC condition. The effect after intravitreal dobesilate injection for CSC might be related to the normalization of retinal architecture.ConclusionsIntravitreal dobesilate may be an effective treatment option for recurrent CSC.
机译:目的报道玻璃体内贝贝硅酸盐治疗复发性中心性浆液性脉络膜视网膜病变(CSC)的解剖学和功能结局。方法这是一例介入性病例报告,其中在复发性CSC病例中玻璃体内注射贝贝硅酸盐。主要措施包括眼底镜检查,Snellen视敏度(VA)测试,荧光素血管造影和光学相干断层扫描(OCT)。慢性CSC病情。玻璃体腔内注射贝贝酸酯治疗CSC可能与视网膜结构正常化有关。结论玻璃体腔内注射贝贝酸酯可能是复发性CSC的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号